Open Access Open Access  Restricted Access Subscription Access

An Important Parameters of Gastric Ulcers Include Objectives, Etiology, Epidemiology, Patho Physiology, Histo Pathology, Diagnosis, Differential Diagnosis, Treatment, Prognosis, Complications and Increasing Health Care Outcomes

Muralinath E., Somaiah T., Mala Kondaiah M., Rama Chandraiah., Krishna Murthy G., Sony Sharlet E., A. Thanuja, Guruprasad. M.

Abstract


In the United States, gastric ulcers are a clinically relevant and common form of peptic ulcer disease that increases morbidity, healthcare consumption, and expenditures, especially when associated with upper gastrointestinal hemorrhage. These lesions are classified as stomach mucosal defects that penetrate the muscularis mucosa and are larger than 5 mm. They arise from an imbalance between the stomach mucosa's defensive mechanisms and harmful luminal substances. Mucosal susceptibility to stomach acid-induced damage is increased when prostaglandin-mediated blood flow, mucus formation, and epithelium healing are disrupted. The main causes of stomach ulcers are explained in this course, including Helicobacter pylori infection and the degradation of mucosal defenses caused by nonsteroidal anti-inflammatory drug (NSAID) use, which is currently more common than H. pylori. The epidemiology, pathophysiology, clinical presentation, diagnostic diagnosis, and evidence-based treatment of stomach ulcers are all thoroughly reviewed in this exercise. In order to improve patient outcomes and safety, participants will become proficient in gastric ulcer risk assessment, alarm feature recognition, proper endoscopic use, Helicobacter pylori elimination and prevention techniques, and complication treatment. This exercise, which is intended for medical professionals, attempts to increase proficiency in identifying stomach ulcers, carrying out recommended diagnoses, and putting an interprofessional management strategy into practice to maximize patient outcomes.


Full Text:

PDF

References


Zhang, T., Zhang, B., & Tang, X. (2025). Global burden of peptic ulcer disease in adolescents and young adults: Trends and disparities from 1990–2021. Archives of Medical Research, 56(8), 103320. https://doi.org/10.1016/j.arcmed.2025.103320

Aro, P., Storskrubb, T., Ronkainen, J., Bolling-Sternevald, E., Engstrand, L., Vieth, M., Stolte, M., Talley, N. J., & Agréus, L. (2006). Peptic ulcer disease in a general adult population: The Kalixanda study: A random population-based study. American Journal of Epidemiology, 163(11), 1025–1034. https://doi.org/10.1093/aje/kwj129

Vakil, N. (2024). Peptic ulcer disease: A review. JAMA, 332(21), 1832–1842. https://doi.org/10.1001/jama.2024.21839

Périco, L. L., Emílio-Silva, M. T., Ohara, R., Rodrigues, V. P., Bueno, G., Barbosa-Filho, J. M., Rocha, L. R. M. D., Batista, L. M., & Hiruma-Lima, C. A. (2020). Systematic analysis of monoterpenes: Advances and challenges in the treatment of peptic ulcer diseases. Biomolecules, 10(2), 265. https://doi.org/10.3390/biom10020265

Hao, W., Zheng, C., Wang, Z., & Ma, H. (2025). Global burden and risk factors of peptic ulcer disease between 1990 and 2021: An analysis from the Global Burden of Disease Study 2021. PLoS ONE, 20(7), e0325821. https://doi.org/10.1371/journal.pone.0325821

Sonnenberg, A., Turner, K. O., & Genta, R. M. (2020). Low prevalence of Helicobacter pylori-positive peptic ulcers in private outpatient endoscopy centers in the United States. American Journal of Gastroenterology, 115(2), 244–250. https://doi.org/10.14309/ajg.0000000000000460

Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J. M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., Rugge, M., Suerbaum, S., Tilg, H., Sugano, K., El-Omar, E. M., & European Helicobacter and Microbiota Study Group. (2022). Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut, 71(9), 1724–1762. https://doi.org/10.1136/gutjnl-2022-327745

Ito, T., Igarashi, H., & Jensen, R. T. (2013). Zollinger–Ellison syndrome: Recent advances and controversies. Current Opinion in Gastroenterology, 29(6), 650–661. https://doi.org/10.1097/MOG.0b013e328365ef64

Rafailidis, P. I., Mourtzoukou, E. G., Varbobitis, I. C., & Falagas, M. E. (2008). Severe cytomegalovirus infection in apparently immunocompetent patients: A systematic review. Virology Journal, 5, 47. https://doi.org/10.1186/1743-422X-5-47

Yeh, P. J., Chiu, C. T., Lai, M. W., Wu, R. C., Kuo, C. J., Hsu, J. T., Su, M. Y., & Le, P. H. (2021). Cytomegalovirus gastritis: Clinicopathological profile. Digestive and Liver Disease, 53(6), 722–728. https://doi.org/10.1016/j.dld.2020.12.019

Ko, K. A., & Lee, D. K. (2025). Nonsteroidal anti-inflammatory drug-induced peptic ulcer disease. Korean Journal of Helicobacter and Upper Gastrointestinal Research, 25(1), 34–41. https://doi.org/10.7704/kjhugr.2025.0004

Scida, S., Russo, M., Miraglia, C., Leandro, G., Franzoni, L., Meschi, T., De' Angelis, G. L., & Di Mario, F. (2018). Relationship between Helicobacter pylori infection and GERD. Acta Bio Medica: Atenei Parmensis, 89(8-S), 40–43. https://doi.org/10.23750/abm.v89i8-S.7924

Zhuo, M., Fang, M., Yin, Y., Wang, J., Wei, Z., Lu, J., & Jia, Y. (2025). Investigating the prevalence burden of peptic ulcer disease in older adults aged 70 years and above from 1990 to 2019: An analysis of Global Burden of Disease studies. European Journal of Gastroenterology & Hepatology, 37(1), 39–46. https://doi.org/10.1097/MEG.0000000000002877

Malfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J. M., Peek, R. M., Schulz, C., Smith, S. I., & Suerbaum, S. (2023). Helicobacter pylori infection. Nature Reviews Disease Primers, 9(1), 19. https://doi.org/10.1038/s41572-023-00431-8

Sengupta, N., Feuerstein, J. D., Jairath, V., Shergill, A. K., Strate, L. L., Wong, R. J., & Wan, D. (2023). Management of patients with acute lower gastrointestinal bleeding: An updated ACG guideline. American Journal of Gastroenterology, 118(2), 208–231. https://doi.org/10.14309/ajg.0000000000002097

McConaghy, J. R., Decker, A., & Nair, S. (2023). Peptic ulcer disease and Helicobacter pylori infection: Common questions and answers. American Family Physician, 107(2), 165–172.

Yew, K. S., George, M. K., & Allred, H. B. (2023). Acute abdominal pain in adults: Evaluation and diagnosis. American Family Physician, 107(6), 585–596.

Laine, L., Barkun, A. N., Saltzman, J. R., Martel, M., & Leontiadis, G. I. (2021). ACG clinical guideline: Upper gastrointestinal and ulcer bleeding. American Journal of Gastroenterology, 116(5), 899–917. https://doi.org/10.14309/ajg.0000000000001245

Barchi, A., Miraglia, C., Violi, A., Cambiè, G., Nouvenne, A., Capasso, M., Leandro, G., Meschi, T., De' Angelis, G. L., & Di Mario, F. (2018). A non-invasive method for the diagnosis of upper gastrointestinal diseases. Acta Bio Medica: Atenei Parmensis, 89(8-S), 40–43. https://doi.org/10.23750/abm.v89i8-S.7924

Kamada, T., Satoh, K., Itoh, T., Ito, M., Iwamoto, J., Okimoto, T., Kanno, T., Sugimoto, M., Chiba, T., Nomura, S., Mieda, M., Hiraishi, H., Yoshino, J., Takagi, A., Watanabe, S., & Koike, K. (2021). Evidence-based clinical practice guidelines for peptic ulcer disease 2020. Journal of Gastroenterology, 56(4), 303–322. https://doi.org/10.1007/s00535-021-01769-0


Refbacks

  • There are currently no refbacks.